Multinational pharmaceutical giant Aspen Pharmacare is prepared to further streamline its global operations. While the company has not officially hoisted a “for sale” sign, leadership has indicated it remains open to further Aspen Pharmacare asset disposals if the price is right. This strategic openness follows the landmark sale of its Asia-Pacific (APAC) division. The R26.5 billion transaction serves as a…